Back to search

Induction of Tumor Antigen-Specific Immunity In Vivo by a Novel Vaccinia Vector Encoding Safety-Modified Simian Virus 40 T Antigen

Data up to Jan 2025

Published1999
Citations35
References37

Total Citations Per Year

Abstract

References (37)

Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.

1994 • 1,400 citations

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer

1996 • 538 citations

DNA Sequences Similar to Those of Simian Virus 40 in Ependymomas and Choroid Plexus Tumors of Childhood

1992 • 422 citations

Vaccinia Virus: A Tool for Research and Vaccine Development

1991 • 410 citations

Simian virus 40-like DNA sequences in human pleural mesothelioma.

1994 • 398 citations

Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability.

1996 • 389 citations

HUMAN EXPOSURE TO SV40: REVIEW AND COMMENT12

1976 • 343 citations

Preparation of Cell Cultures and Vaccinia Virus Stocks

1998 • 278 citations

Simian virus-40 large-T antigen binds p53 in human mesotheliomas

1997 • 259 citations

Molecular Characterization of Defective Antigen Processing in Human Prostate Cancer

1995 • 240 citations

Isometric Muscle Strength in Youth Assessed by Hand-held Dynamometry

2011 • 212 citations

The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas

1997 • 212 citations

Mutational analysis of simian virus 40 T antigen: isolation and characterization of mutants with deletions in the T-antigen gene.

1983 • 210 citations

Natural Simian Virus 40 Strains Are Present in Human Choroid Plexus and Ependymoma Tumors

1995 • 209 citations

Simian virus 40, poliovaccines and human tumors: a review of recent developments

1997 • 178 citations

A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas.

1998 • 174 citations

Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus

1990 • 172 citations

SV40-like sequences in human bone tumors.

1996 • 171 citations

Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7

1991 • 160 citations

Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine

1997 • 144 citations

IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases.

1995 • 117 citations

Genetic Control of the Cytotoxic T Cell Response to SV40 Tumor-Associated Specific Antigen

1979 • 116 citations

Mutational Analysis of Simian Virus 40 T Antigen: Isolation and Characterization of Mutants with Deletions in the T-Antigen Gene

1983 • 112 citations

Tumour prevention and rejection with recombinant vaccinia

1987 • 101 citations

Simian virus 40 large T antigen alters the phosphorylation state of the RB-related proteins p130 and p107

1996 • 100 citations

Transformation of a continuous rat embryo fibroblast cell line requires three separate domains of simian virus 40 large T antigen

1992 • 98 citations

Nuclear preparations of SV40-transformed cells contain tumors-pecific transplantation antigen activity

1977 • 93 citations

SV40 and human brain tumors.

1990 • 83 citations

Recognition by cytotoxic T lymphocytes of cells expressing fragments of the SV40 tumor antigen.

1983 • 81 citations

An Endoplasmic Reticulum-Targeting Signal Sequence Enhances the Immunogenicity of an Immunorecessive Simian Virus 40 Large T Antigen Cytotoxic T-Lymphocyte Epitope

1998 • 76 citations

Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen.

1996 • 59 citations

Recognition of simian virus 40 T antigen by cytotoxic T lymphocytes.

1990 • 51 citations

Distribution of HLA Antigens

1990 • 47 citations

A DNA replication-positive mutant of simian virus 40 that is defective for transformation and the production of infectious virions

1990 • 30 citations

The HLA System: A New Approach

2011 • 18 citations

SV40 large tumor antigen associated synthetic peptides define native antigenic determinants and induce protective tumor immunity in mice

1994 • 15 citations

Host proteins that bind to or mimic SV40 large T antigen: using antibodies to look at protein interactions and their significance.

1989 • 9 citations

Cited By (0)

Loading...
Induction of Tumor Antigen-Specific Immunity In Vivo by a Novel Vaccinia Vector Encoding… (1999) – JNCI Journal of the National Cancer Institute | Metascience Observatory Explorer